TNF Pharmaceuticals, Inc. (TNFA)

TNF Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.17	2.68	0.75	0.56	0.15
Short-Term Investments	8.35	2.24	4.09	11	-
Cash & Short-Term Investments	8.52	4.92	4.84	11.56	0.15
Cash Growth	73.02%	1.80%	-58.16%	7695.20%	12.32%
Prepaid Expenses	0.89	0.89	0.57	1.11	0
Total Current Assets	9.41	5.82	5.4	12.67	0.15
Property, Plant & Equipment	0.01	0.05	0.14	0.15	0.53
Long-Term Investments	1.5	1.5	1.5	1.5	-
Goodwill	10.5	10.5	10.5	10.5	-
Total Assets	21.42	17.86	17.54	24.81	0.68
Accounts Payable	2.52	3.08	2.36	0.87	1.1
Accrued Expenses	0.39	0.64	0.32	0.12	0.7
Short-Term Debt	-	-	-	-	0.07
Current Portion of Leases	0.01	0.05	0.07	0.05	0.48
Other Current Liabilities	3.79	1.22	0.03	-	-
Total Current Liabilities	6.7	4.99	2.77	1.04	2.35
Long-Term Debt	-	-	-	-	3.53
Long-Term Leases	-	-	0.08	0.1	0.05
Other Long-Term Liabilities	-	0.1	-	0.03	-
Total Liabilities	6.7	5.09	2.84	1.17	5.93
Common Stock	0	0	0	102.06	0
Additional Paid-In Capital	138.78	114.2	108.31	-	43.41
Retained Earnings	-129.14	-101.98	-93.76	-78.56	-48.67
Total Common Equity	9.65	12.23	14.55	23.5	-5.26
Shareholders' Equity	14.72	12.77	14.7	23.65	-5.26
Total Liabilities & Equity	21.42	17.86	17.54	24.81	0.68
Total Debt	0.01	0.05	0.14	0.15	4.13
Net Cash (Debt)	8.51	4.87	4.69	11.41	-3.98
Net Cash Growth	74.54%	3.83%	-58.86%	-	-
Net Cash Per Share	3.49	3.16	3.63	9.78	-4.24
Filing Date Shares Outstanding	10.13	2.16	1.32	1.27	1.34
Total Common Shares Outstanding	3.36	2.02	1.32	1.26	1.34
Working Capital	2.71	0.83	2.63	11.63	-2.2
Book Value Per Share	2.87	6.06	11.06	18.72	-3.94
Tangible Book Value	-0.85	1.73	4.05	13	-5.26
Tangible Book Value Per Share	-0.25	0.86	3.08	10.36	-3.94

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q